Samsung to Invest $90 Billion in South Korea to Expand AI Chip, Display, and Battery Production 
Chinese Copper Foil Maker Londian Files U.S. IPO as EV Battery Demand Grows 
TetherMax Rebranding Highlights Official Exchange Partnerships as Foundation of Trust 
Trump Reports $1.4 Billion in Crypto Income as Digital Assets Become Top Wealth Source 
Apple Expands iPhone Lineup, Boosts Foldable iPhone Production Plans Through 2027 
Kioxia Bets on AI Memory Boom With Next-Gen NAND Production in Japan 
Kuaishou Stock Jumps as Kling AI Secures $2 Billion Funding Round 
Anthropic Tightens AI Access Controls After Reports of China-Based Workarounds 
EU Chip Industry Faces Growing Risks From China Export Controls and U.S. Technology Dependence: Report 
Suncorp Cuts 2026 Premium Growth Forecast as Australia, New Zealand Markets Weaken 
SK Holdings, KKR Launch $1.3B Renewable Energy Venture in South Korea 
Meta Stock Jumps as AI Cloud Expansion Challenges AWS, Microsoft, and Google 
Kawasaki Heavy Shares Slide on Report of ¥200 Billion Capital Raise Plan 
DOJ Seeks Dismissal of Fraud Charges Against Gautam Adani in U.S. Court 
Meta CEO Zuckerberg Says AI Agent Development Has Slowed Despite Massive AI Investment 
Apple Eyes Chinese Memory Chips as AI Shortage Pressures iPhone Supply Chain 
Canada blocked bulk exports of prescription drugs to the US as it would cause or worsen a drug shortage at home.
The said importation from Canada is President Donald Trump's strategy of lowering some drug prices in the US, which he touted in his debate with President-elect Joe Biden.
Many Canadian drug suppliers opposed Trump's plan as it could lead to shortages,
The “Importation Prescription Drugs” rule in the US would allow licensed US pharmacists or wholesalers to import in bulk certain prescription drugs intended for the Canadian market.
According to Canada's Health Minister Patty Hajdu, companies will be required to provide information to assess existing or potential shortages, which could be as quick as within 24 hours if there is a serious or imminent health risk.
Hajdu emphasized the need for vigilance in maintaining the national drug supply noting that Canada is a small market, representing 2 percent of global drug sales, that sources 68 percent of its drugs internationally.
Canadian Prime Minister Justin Trudeau said in September that his priority was protecting the needs of Canadians in terms of pharmaceutical supplies.
